Dr. Reddy's Laboratories Limited Dividend History (RDY)
🤑 Dr. Reddy's Laboratories Limited has distributed a total of 20 dividends from 2004 to 2024
📈 During this 20 period their dividend has seen a 342.27% increase in the payout amount
About Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited is an Indian multinational pharmaceutical company founded in 1984 by Anji Reddy. Headquartered in Hyderabad, India, the company is known for developing a wide range of generic medications, active pharmaceutical ingredients (APIs), and proprietary products. As of 2023, Erez Israeli serves as the CEO. Dr. Reddy's plays a significant role in global healthcare by making high-quality medicines more accessible and affordable. In recent years, the company has expanded its operations across regions like North America, Europe, and Emerging Markets, reflecting a strong global presence. With several manufacturing facilities and research centers worldwide, Dr. Reddy's continues to innovate and address unmet medical needs. The company's diverse product portfolio spans various therapeutic categories, and its commitment to sustainability underscores its role as a responsible corporate entity in the pharmaceutical industry.
Apple Inc.
Microsoft Corporation
Johnson & Johnson
Procter & Gamble Co.
Coca-Cola Co.
PepsiCo, Inc.
Exxon Mobil Corporation
Verizon Communications Inc.
AT&T Inc.
Chevron CorporationThe global coccidioidomycosis drugs market is expected to grow at a CAGR of 4.9% and reach a valuation of US$ 634.3 million by 2034, driven by increased awareness, development in antifungals, and improved access to healthcare in endemic regions.
GlobeNewswire Inc. · Published on Wed Dec 04 2024The report provides an overview of the global clinical trials landscape for Zollinger-Ellison Syndrome (Gastrinoma), including details on trial numbers, enrollment trends, and prominent companies and drugs involved in ongoing trials.
GlobeNewswire Inc. · Published on Wed Nov 06 2024The global antiemetics drugs market is expected to grow at a CAGR of around 6% by 2030, driven by the rising incidence of conditions and treatments that cause nausea and vomiting, such as chemotherapy, radiation therapy, and surgical procedures.
GlobeNewswire Inc. · Published on Thu Oct 10 2024Previous Payouts (20)
The most recent dividend Dr. Reddy's Laboratories Limited paid out was on August 12, 2024 (117 days ago) for $0.476153 per share
| Pay Date | Amount |
|---|---|
| August 12, 2024 | $0.476153 |
| August 11, 2023 | $0.482608 |
| August 12, 2022 | $0.3784342 |
| August 17, 2020 | $0.3333635 |
| August 15, 2019 | $0.282229 |
| August 9, 2018 | $0.291977 |
| August 10, 2017 | $0.313922 |
| August 9, 2016 | $0.299468 |
| August 17, 2015 | $0.31292 |
| August 15, 2014 | $0.291545 |
| August 15, 2013 | $0.264393 |
| August 6, 2012 | $0.247636 |
| August 11, 2011 | $0.254654 |
| August 17, 2010 | $0.24126 |
| August 12, 2009 | $0.130398 |
| August 18, 2008 | $0.08882 |
| August 10, 2007 | $0.092902 |
| August 21, 2006 | $0.10725 |
| August 16, 2005 | $0.11475 |
| August 24, 2004 | $0.10766 |
Dividend data last updated Sat, 07 Dec 2024 12:40:50 GMT UTC